Feasibility and Preliminary Efficacy of a Theory-driven BALANCE Dietary Program Among Patients With Type 2 Diabetes
BALANCE
1 other identifier
interventional
30
1 country
1
Brief Summary
This study explores the effect of an individualized dietary intervention program based on COM-B theory on improving health outcomes in patients with T2DM, improvement in metabolic health indicators and an increased diabetes remission rate, as well as changes in dietary adherence, self-management ability, and self-efficacy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable type-2-diabetes-mellitus
Started Jun 2025
Shorter than P25 for not_applicable type-2-diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedFirst Submitted
Initial submission to the registry
March 2, 2026
CompletedFirst Posted
Study publicly available on registry
March 16, 2026
CompletedMarch 16, 2026
March 1, 2026
6 months
March 2, 2026
March 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
HbA1c
HbA1c will be measured using High-Performance Liquid Chromatography (HPLC), the internationally recognized reference method for HbA1c quantification. Venous blood samples will be collected in EDTA-anticoagulated tubes and analyzed by ion-exchange HPLC, which separates hemoglobin fractions based on their interaction with a chromatography column. Results will be reported as a percentage (%) per NGSP/DCCT standards, with parallel reporting in mmol/mol per IFCC standards. All analyses will be performed in a certified laboratory participating in external quality assessment (EQA) programs to ensure inter-laboratory comparability and result accuracy.
before the intervention and from enrollment to the end of treatment at 12 and 24 weeks
Secondary Outcomes (23)
FBG (Fasting Blood Glucose)
before the intervention and from enrollment to the end of treatment at 12 and 24 weeks
TG (Triglycerides)
before the intervention and from enrollment to the end of treatment at 12 and 24 weeks
TC (Total Cholesterol)
before the intervention and from enrollment to the end of treatment at 12 and 24 weeks
DKT (Diabetes Knowledge Test)
before the intervention and from enrollment to the end of treatment at 12 and 24 weeks
DSES (Diabetes Self-Efficacy Scale)
before the intervention and from enrollment to the end of treatment at 12 and 24 weeks
- +18 more secondary outcomes
Study Arms (2)
The BALANCE dietary intervention
EXPERIMENTALThe intervention group will implement a BALANCE dietary intervention based on the COM-B theory model and a TDF framework, including ① psychological capability education: intensified education on diabetes knowledge; ② physical capability education: intensified training in practical skills for dietary management; ③ motivation management: action planning, behavior goal setting, problem solving, reward mechanisms, and establishing role models; ④ support and supervision: empowerment management via a WeChat group, social support, and guidance based on indicator monitoring on the clinician side of a mini-program.
usual care
ACTIVE COMPARATORA routine dietary management will be implemented, including health guidance, WeChat group management, and supervision and management
Interventions
Intensified education on diabetes knowledge
Intensified training in practical skills for dietary management
action planning, behavior goal setting, problem solving, reward mechanisms, and establishing role models
empowerment management via a WeChat group, social support, and guidance based on indicator monitoring on the clinician side of a mini-program
a routine dietary management model will be implemented, including health guidance, WeChat group management, and supervision and management
Eligibility Criteria
You may qualify if:
- Meet 1999 WHO diagnostic criteria for type 2 diabetes mellitus (diabetes symptoms plus random plasma glucose ≥11.1 mmol/L, or fasting plasma glucose ≥7.0 mmol/L, or 2-hour plasma glucose ≥11.1 mmol/L after OGTT) Glycated hemoglobin (HbA1c) between 7% and 10%;
- Stable glucose-lowering medication regimen as assessed by physician;
- Age 18-60 years;
- Light physical labor in the past 6 months (work mainly involving standing or small amount of walking);
- Willing to participate voluntarily, understand study content, and able to attend regular follow-up;
You may not qualify if:
- Currently using weight-loss medications;
- Significant renal insufficiency (creatinine ≥1.5 mg/dL or 133 μmol/L);
- Significant liver dysfunction (ALT more than 2 times the upper limit of normal);
- History of stroke or myocardial infarction;
- Other serious diseases including malignant tumors, psychiatric disorders, anorexia, or gastrointestinal diseases;
- Pregnancy, planning pregnancy, postpartum status, or breastfeeding;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Luhe Hospital, Capital Medical University
Beijing, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ji Meihua
Capital Medical University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 2, 2026
First Posted
March 16, 2026
Study Start
June 1, 2025
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
March 16, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share